BiomeDx receives funding from the Austrian Research Promotion Agency (FFG) to investigate the microbiome of…
Catia PacificoMay 9, 2023
BiomeDx presents new insights about the intestinal microbiome and response to immunotherapy at CIMT 2023…
Catia PacificoMay 5, 2023
BiomeDx advances to finals of EIT Health Catapult Program 2022-2023 VIENNA, 3rd April 2023: BiomeDx…
Catia PacificoApril 3, 2023
VIENNA, 16th March 2023: BiomeDx, a leader in AI-driven solutions for healthcare and biotech, is…
Catia PacificoMarch 16, 2023
Co-founder Nikolaus Gasche attends DACH Healthcare Innovation Summit 2023 MUNICH, 2-3rd March 2023: Biome Diagnostics…
Catia PacificoMarch 3, 2023
Insights on Microbiome and Cancer Immunotherapy at BIGMED-Austria Seminar VIENNA, 18th February 2023: Our very…
Catia PacificoFebruary 18, 2023
Biome Diagnostics ranks amongst the best Austrian startups 2022 VIENNA, November 25 For the last…
Catia PacificoNovember 25, 2022